Every xAI cofounder, other than Elon Musk, has now exited the company. Dozens of people who served on xAI’s engineering and ...
Dr. Simon Sumer explains how AI‑driven protein design is shortening development cycles, improving screening efficiency, and ...
47m
IDEAYA Biosciences, Inc. (IDYA) PT Increased as Wedbush Highlights Positive OptimUM-02 Trial Readout
TheFly reported on April 14 that Wedbush Securities increased its price target on IDYA from $52 to $58 while maintaining an ...
Scientists say they've made a key breakthrough that would allow robots to figure out complex tasks on their own — but experts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results